UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
| |
| |
FORM 8-K |
| |
| |
CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
| |
| |
June 20, 2019 |
Date of Report (Date of Earliest Event Reported) |
| |
| |
ULTRALIFE CORPORATION |
(Exact name of registrant as specified in its charter) |
| |
Delaware | 000-20852 | 16-1387013 |
(State of incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
| |
2000 Technology Parkway, Newark, New York 14513 |
(Address of principal executive offices) (Zip Code) |
| |
(315) 332-7100 |
(Registrant’s telephone number, including area code) |
| |
None |
(Former name or former address, if changed since last report) |
Securities registered pursuant to Section 12(b) of the Act: |
Common Stock, $0.10 par value per share | ULBI | NASDAQ |
(Title of each class) | (Trading Symbol) | (Name of each exchange on which registered) |
| |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below): |
| |
☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging Growth Company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ |
Item 8.01 Other Events
In a press release dated June 20, 2019, Ultralife Corporation (NASDAQ: ULBI) announced that it has received a fixed price, indefinite-delivery/indefinite-quantity contract for purchases not to exceed $9.986 million from the Naval Air Warfare Center Aircraft Division for our Universal Vehicle Adaptors (“UVA’s”) in support of the Family of Special Operations Vehicles Ground Mobility Vehicle and Mine Resistant Ambush Protected platforms. The award is for five years with the amounts and timing of deliveries based on program requirements. Also, an initial delivery order has been received for approximately $1.4 million and shipments in 2019.
Item 9.01 Financial Statements, Pro Forma Financials and Exhibits
(d) Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Date: June 20, 2019 | | ULTRALIFE Corporation |
| | | |
| | | |
| | By: | /s/ Philip A. Fain |
| | | Philip A. Fain |
| | | Chief Financial Officer and Treasurer |
